NASDAQ:ACIU
AC Immune SA
- Stock
Last Close
3.91
26/07 20:00
Market Cap
342.23M
Beta: 0.59
Volume Today
199.26K
Avg: 96.74K
PE Ratio
−3.03
PFCF: −3.86
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
average inventory | 1.39M - | 1.43M 2.48% | -485K 134.04% | -679.50K 40.10% | -699.50K 2.94% | -1.66M 137.24% | -1.66M 0.12% | -701.50K 57.78% | 0.50 100.00% | ||
average payables | 1.65M - | 2.88M 74.21% | 2.56M 10.90% | 1.54M 40.10% | 1.06M 30.93% | 1.16M 9.67% | 2.09M 80.01% | 1.47M 29.97% | 1.30M 11.05% | ||
average receivables | 13.15M - | 861K 93.45% | 2.56M 197.50% | 3.91M 52.63% | 2.75M 29.65% | 1.66M 39.67% | 1.66M 0.12% | 1.10M 33.70% | 8.23M 647.53% | ||
book value per share | 0.42 - | 1.28 202.74% | 2.84 121.61% | 2.04 28.32% | 2.87 41.00% | 3.86 34.34% | 3.00 22.33% | 3.10 3.27% | 2.02 34.65% | 1.90 6.22% | |
capex per share | -0.00 - | -0.00 90.63% | -0.02 307.42% | -0.03 75.08% | -0.03 4.37% | -0.03 11.14% | -0.02 11.13% | -0.04 48.17% | -0.01 57.82% | -0.01 36.22% | |
capex to depreciation | -0.43 - | -0.85 97.93% | -3.23 280.37% | -3.11 3.92% | -1.93 37.77% | -1.11 42.45% | -0.87 22.06% | -1.10 26.27% | -0.53 52.04% | -0.36 31.15% | |
capex to operating cash flow | 0.01 - | -0.01 176.21% | 0.16 2,976.80% | 0.08 48.78% | 0.04 48.32% | -0.03 180.98% | 0.03 183.97% | 0.04 39.94% | 0.02 58.01% | 0.01 21.27% | |
capex to revenue | -0.00 - | -0.01 47.61% | -0.04 520.42% | -0.09 129.73% | -0.26 190.30% | -0.02 93.43% | -0.11 551.18% | -0.31 - | -0.05 82.81% | ||
cash per share | 0.06 - | 1.38 2,214.64% | 3.04 119.95% | 2.17 28.63% | 3.02 39.05% | 4.09 35.56% | 3.14 23.14% | 2.64 15.82% | 1.47 44.52% | 1.22 17.07% | |
days of inventory on hand | |||||||||||
days payables outstanding | |||||||||||
days sales outstanding | 313.38 - | 2.95 99.06% | 22.11 649.23% | 66.98 202.99% | 208.12 210.72% | 4.60 97.79% | 45.42 887.45% | 74.21 - | 386.38 420.69% | ||
debt to assets | 0.00 - | 0.00 11.92% | 0.01 268.61% | 0.01 4.15% | 0.01 19.54% | 0.02 35.34% | 0.02 26.98% | ||||
debt to equity | 0.00 - | 0.00 13.74% | 0.01 265.88% | 0.01 3.31% | 0.01 21.59% | 0.02 32.13% | 0.02 31.34% | ||||
dividend yield | |||||||||||
earnings yield | 0.01 - | 0.02 90.47% | -0.01 145.18% | -0.04 231.53% | -0.09 150.23% | 0.08 187.98% | -0.19 343.00% | -0.22 13.62% | -0.45 108.56% | -0.15 66.08% | |
enterprise value | 862.01M - | 780.57M 9.45% | 511.90M 34.42% | 621.58M 21.43% | 418.84M 32.62% | 391.99M 6.41% | 169.03M 56.88% | 259.69M 53.63% | 128.76M 50.42% | 281.04M 118.26% | |
enterprise value over ebitda | 78.04 - | 37.92 51.40% | -78.01 305.70% | -28.73 63.17% | -8.64 69.94% | 8.43 197.61% | -2.85 133.86% | -3.70 29.74% | -1.82 50.88% | -5.58 206.73% | |
ev to operating cash flow | -48.91 - | 17.71 136.20% | -90.67 612.05% | -28.13 68.97% | -9.50 66.22% | 7.10 174.71% | -2.84 140.01% | -3.95 39.19% | -1.75 55.73% | -4.65 165.81% | |
ev to sales | 28.48 - | 19.97 29.88% | 22.05 10.43% | 30.69 39.17% | 58.22 89.72% | 3.53 93.94% | 10.95 210.26% | 32.72 - | 18.99 41.97% | ||
free cash flow per share | -0.32 - | 0.79 346.96% | -0.13 116.51% | -0.42 218.90% | -0.74 78.30% | 0.76 201.69% | -0.85 212.72% | -0.91 7.05% | -0.90 1.78% | -0.72 19.28% | |
free cash flow yield | -0.02 - | 0.05 349.33% | -0.01 119.27% | -0.03 225.21% | -0.08 149.35% | 0.09 214.54% | -0.19 304.10% | -0.20 7.88% | -0.47 135.58% | -0.17 63.79% | |
graham net net | 0.29 - | 1.25 328.46% | 2.79 123.61% | 1.94 30.42% | 2.76 42.16% | 3.71 34.57% | 2.82 23.91% | 2.26 20.13% | 1.27 43.64% | 1.09 13.99% | |
graham number | 1.36 - | 3.25 138.99% | 3.01 7.38% | 4.59 52.65% | 7.30 58.84% | 7.48 2.44% | 7.63 2.09% | 8.24 7.91% | 6.21 24.62% | 5.23 15.79% | |
income quality | -1.64 - | 2.17 232.58% | 0.80 63.42% | 0.84 5.14% | 0.87 3.41% | 1.22 40.47% | 0.96 20.90% | 0.90 6.38% | 1.04 15.54% | 1.11 7.12% | |
intangibles to total assets | 0 - | 0 | 0 | 0 | 0 | 0 | 0 | 0.19 Infinity% | 0.27 40.61% | 0.28 1.71% | |
interest coverage | 2.68K - | 716.31 73.26% | -40.84 105.70% | -153.33 275.40% | -166.28 8.45% | 23.51 114.14% | -332.93 1,515.88% | -135.99 59.15% | -199.57 46.75% | -304.68 52.67% | |
interest debt per share | 0.00 - | 0.00 550% | 0.01 988.77% | 0.01 84.93% | 0.01 39.64% | 0.07 415.31% | 0.03 50.77% | 0.05 39.13% | 0.04 18.90% | 0.04 14.81% | |
inventory turnover | |||||||||||
invested capital | 0.00 - | 0.00 13.74% | 0.01 265.88% | 0.01 3.31% | 0.01 21.59% | 0.02 32.13% | 0.02 31.34% | ||||
market cap | 865.32M - | 857.09M 0.95% | 664.11M 22.52% | 745.56M 12.27% | 574.79M 22.91% | 582.67M 1.37% | 327.70M 43.76% | 338.99M 3.44% | 157.55M 53.52% | 356.04M 125.99% | |
net current asset value | 22.84M - | 70.46M 208.51% | 141.17M 100.37% | 114.36M 18.99% | 174.00M 52.15% | 265.97M 52.86% | 208.50M 21.60% | 173.17M 16.95% | 111.15M 35.82% | 102.98M 7.35% | |
net debt to ebitda | -0.30 - | -3.72 1,142.17% | 23.20 723.92% | 5.73 75.29% | 3.22 43.89% | -4.10 227.53% | 2.68 165.35% | 1.13 57.79% | 0.41 64.04% | 1.49 266.14% | |
net income per share | 0.19 - | 0.37 88.66% | -0.14 138.71% | -0.46 225.09% | -0.82 78.93% | 0.64 178.12% | -0.86 234.20% | -0.97 12.75% | -0.85 13.05% | -0.64 24.38% | |
operating cash flow per share | -0.32 - | 0.80 350.14% | -0.11 114.16% | -0.39 241.80% | -0.71 85.04% | 0.78 209.72% | -0.83 205.84% | -0.88 5.88% | -0.88 0.46% | -0.71 18.99% | |
payables turnover | |||||||||||
receivables turnover | 1.16 - | 123.70 10,520.71% | 16.51 86.65% | 5.45 67.00% | 1.75 67.82% | 79.36 4,425.14% | 8.04 89.87% | 4.92 - | 0.94 80.79% | ||
research and ddevelopement to revenue | 0.53 - | 0.44 18.08% | 1.11 154.56% | 1.61 45.24% | 6.15 281.67% | 0.45 92.62% | 3.86 748.68% | 15.33 - | 3.69 75.94% | ||
return on tangible assets | 0.35 - | 0.25 28.49% | -0.05 117.93% | -0.20 340.11% | -0.26 29.57% | 0.15 158.58% | -0.26 271.31% | -0.35 32.97% | -0.52 50.93% | -0.41 21.54% | |
revenue per share | 0.55 - | 0.71 29.14% | 0.46 34.33% | 0.35 23.79% | 0.12 67.06% | 1.57 1,251.71% | 0.21 86.35% | 0.05 - | 0.17 271.07% | ||
roe | 0.46 - | 0.29 37.68% | -0.05 117.47% | -0.23 353.56% | -0.29 26.90% | 0.17 158.15% | -0.29 272.80% | -0.31 9.18% | -0.42 33.05% | -0.34 19.37% | |
roic | 0.46 - | 0.24 47.10% | -0.11 146.02% | -0.19 73.80% | -0.27 41.24% | 0.15 156.50% | -0.28 281.72% | -0.33 18.93% | -0.41 22.15% | -0.32 21.17% | |
sales general and administrative to revenue | 0.07 - | 0.05 20.98% | 0.20 290.27% | 0.31 52.08% | 1.05 239.44% | 0.08 91.93% | 0.72 746.66% | 4.01 - | 0.71 82.19% | ||
shareholders equity per share | 0.42 - | 1.28 202.74% | 2.84 121.61% | 2.04 28.32% | 2.87 41.00% | 3.86 34.34% | 3.00 22.33% | 3.10 3.27% | 2.02 34.65% | 1.90 6.22% | |
stock based compensation to revenue | 0.01 - | 0.01 99.12% | 0.06 310.68% | 0.08 37.41% | 0.35 348.99% | 0.03 92.71% | 0.26 937.87% | 0.85 - | 0.29 65.15% | ||
tangible asset value | 23.47M - | 71.04M 202.74% | 142.38M 100.41% | 116.84M 17.94% | 177.62M 52.02% | 272.44M 53.38% | 215.48M 20.91% | 181.56M 15.74% | 118.58M 34.69% | 110.23M 7.04% | |
tangible book value per share | 0.42 - | 1.28 202.74% | 2.84 121.61% | 2.04 28.32% | 2.87 41.00% | 3.86 34.34% | 3.00 22.33% | 2.42 19.17% | 1.42 41.42% | 1.30 8.29% | |
working capital | 25.25M - | 73.25M 190.10% | 144.97M 97.93% | 119.78M 17.38% | 179.85M 50.15% | 275.26M 53.06% | 217.75M 20.89% | 182.61M 16.14% | 116.61M 36.14% | 111.58M 4.32% |
All numbers in USD (except ratios and percentages)